Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Paul A Bunn

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Bunn, Paul

Item TypeName
Academic Article A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article New treatment agents for advanced small cell and non-small cell lung cancer.
Academic Article A phase I study of carboplatin and paclitaxel in non-small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article Combination paclitaxel and platinum in the treatment of lung cancer: US experience.
Academic Article Future directions in therapeutic approaches for small cell lung cancer.
Academic Article Phase I study of cisplatin, etoposide, and paclitaxel in patients with extensive-stage small cell lung cancer: a University of Colorado Cancer Center study.
Academic Article The North American experience with paclitaxel combined with cisplatin or carboplatin in lung cancer.
Academic Article Induction paclitaxel/carboplatin in early stage non-small cell lung cancer. Bimodality Lung Oncology Team.
Academic Article Induction chemotherapy before surgery for early-stage lung cancer: A novel approach. Bimodality Lung Oncology Team.
Academic Article Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non--small-cell lung cancer: a Southwest Oncology Group trial.
Academic Article Current therapy of small cell lung cancer.
Academic Article Exisulind in combination with docetaxel inhibits growth and metastasis of human lung cancer and prolongs survival in athymic nude rats with orthotopic lung tumors.
Academic Article Bradykinin antagonist dimer, CU201, inhibits the growth of human lung cancer cell lines in vitro and in vivo and produces synergistic growth inhibition in combination with other antitumor agents.
Academic Article Defining the role of paclitaxel in lung cancer: summary of recent studies and implications for future directions.
Academic Article Chemotherapy for elderly patients with advanced non-small-cell lung cancer.
Academic Article Taxanes in the treatment of advanced (stage III and IV) non-small cell lung cancer (NSCLC): recent developments.
Academic Article Triplet chemotherapy with gemcitabine, a platinum, and a third agent in the treatment of advanced non-small cell lung cancer.
Academic Article Multicenter phase I/II study of cetuximab with paclitaxel and carboplatin in untreated patients with stage IV non-small-cell lung cancer.
Academic Article Fluorescence in situ hybridization subgroup analysis of TRIBUTE, a phase III trial of erlotinib plus carboplatin and paclitaxel in non-small cell lung cancer.
Academic Article A phase I study of paclitaxel, etoposide, and cisplatin in extensive stage small cell lung cancer.
Academic Article A phase I/II trial of paclitaxel, carboplatin, and gemcitabine in untreated patients with advanced non-small cell lung cancer.
Academic Article Preclinical and clinical studies of docetaxel and exisulind in the treatment of human lung cancer.
Academic Article Paclitaxel enhances in vitro radiosensitivity of squamous carcinoma cell lines of the head and neck.
Academic Article A phase I study of cisplatin, etoposide, and paclitaxel in small cell lung cancer.
Academic Article New chemotherapeutic agents prolong survival and improve quality of life in non-small cell lung cancer: a review of the literature and future directions.
Academic Article A phase I trial of paclitaxel plus carboplatin in untreated patients with advanced non-small cell lung cancer.
Academic Article Surgery with or without preoperative paclitaxel and carboplatin in early-stage non-small-cell lung cancer: Southwest Oncology Group Trial S9900, an intergroup, randomized, phase III trial.
Academic Article A randomized, phase II, biomarker-selected study comparing erlotinib to erlotinib intercalated with chemotherapy in first-line therapy for advanced non-small-cell lung cancer.
Concept Paclitaxel

Search Criteria
  • Paclitaxel

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)